Last week leaders in global health and tropical medicine convened in Philadelphia to talk about the latest scientific advances in their field as well as the current status of efforts to control tropica

Merck Serono plans to double its donation from 25 million tablets to 50 million tablets and will continue a commitment to donations indefinitely, until schistosomiasis has been eliminated in Africa.

We're at the beginning of something big.

Sabin president, Dr. Peter Hotez recently published a new editorial in PLoS Neglected Tropical Diseases (NTDs) which calls on the NTD community to use the upcoming presidential and congressional elections as an opportunity to advocate for increased NTD funding. Dr.

2012 Albert B. Sabin Gold Medal Award Call for Nominations

November 30, 2011

The Sabin Vaccine Institute is honored to invite you to nominate a distinguished colleague for the 2012 Albert B. Sabin Gold Medal Award.

How to Nominate Your Distinguished Colleague

In order to nominate your colleague for the Gold Medal Award, provide a one-page explanation of the nominee’s most important vaccine research or advocacy contributions and why you believe they are particularly important. Please submit your nomination no later than Friday, December 16, 2011 to the following address:

Sabin

This is the fifth post in a blog mini-series from the Dengue Vaccine Initiativeabout the collaborative work being done to ensure future access to dengue vaccines in developing nations.

Late last week, the GAVI Alliance board announced its plan to fund the introduction of vaccine

This is the fourth post in a blog mini-series from the Dengue Vaccine Initiativeabout the collaborative work being done to ensure future access to dengue vaccines in developing nations.

Financing research and development (R&D) for neglected tropical disease (NTDs) is a big challenge. The problem? Market failure.

Pages